Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04378959 · ClinicalTrials.gov registry record · NA
Lidocaine Patch for Neck Pain
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 76
- Enrollment target
NCT04378959: Completed NA study, sponsored by Johns Hopkins University.
NCT04378959 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 76 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04378959, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 76 participants
- Enrollment target
Study Summary
In this randomized, double-blind, placebo-controlled crossover study, up to 84 patients with non-radicular neck pain will be allocated in a 1:1 ratio to receive up to 3 topical lidocaine or placebo patches, to be applied 12 hours per day. At the end of 4 weeks, patients will return for patients' post-phase I treatment evaluation. Patients will crossover to receive up to 3 identical-looking topical patches of the treatment patients did not receive, to be applied in the same fashion for the same 4-week period. The primary outcome measure will be average neck pain over the past week, 4 weeks post-treatment. A positive categorical outcome (i.e. responder) will be defined as a 2-point or greater decrease in average neck pain coupled with a patient global impression of change score \>/= 5/7.
Interventions
- DRUG Placebo patch
- DRUG Lidocaine patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2021-02-01 |
| Est. Completion | 2023-06-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04378959
The ClinicalTrials.gov registry entry for NCT04378959 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo patch is the first listed.
NCT04378959 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04378959 about?
NCT04378959 is a clinical study titled "Lidocaine Patch for Neck Pain". In this randomized, double-blind, placebo-controlled crossover study, up to 84 patients with non-radicular neck pain will be allocated in a 1:1 ratio to receive up to 3 topical lidocaine or placebo patches, to be applied 12 hours per day. At the end of 4 weeks, patients will return for patients' pos...
What is the current status of trial NCT04378959?
This trial is currently completed. It is a NA study. The enrollment target is 76 participants. The study started on 2021-02-01. Estimated completion is 2023-06-02.
What interventions are being tested in trial NCT04378959?
The interventions under investigation include: Placebo patch (DRUG), Lidocaine patch (DRUG).
Who is sponsoring clinical trial NCT04378959?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.